CONSTANTINOS A. CONSTANTINIDES MD, PhD, FEBU
CURRICULUM VITAE
NAME:
Constantinos A. Constantinides
DATE OF BIRTH:
July 11, 1955
PLACE OF BIRTH:
Athens
ADDRESS:
Avras 3, Ekali, Athens, Greece
CURRENT POSITION:
Director and Chairman of the 1st Department of Urology of
Athens Medical School at LAIKO Hospital
Professor of Urology - Athens University Medical School
1. Training

1979: Graduate of the Athens University Medical School

January 1982-Μarch 1982: Honorary Clinical Assistant in the Vascular Surgery
Department of Brompton Hospital in London.

Apri11987: Completion of Urology training in LAIKO Hospital, Athens, under
Professor C. Dimopoulos

April 1987- November 1988: (Swiss Government scholarship) - Fellowship in Urology
in the Urology Department of the University of Zurich under Professor D. Hauri
focusing on ESWL, radical cystoprostatectomy, orthotopic neobladder formation and
erectile dysfunction

January 1989: PhD in Urology
2. Academic work

1989 - today: Training of the 5th-year medical students of the Athens University
Medical School

March 1991: Lecturer in the 1st Urological Department at LAIKO Hospital

1993: Fellow of the European Board of Urology (FEBU).

1996-2000: Member of the Scientific Committee of the LAIKO Hospital

Supervisor of 18 medical PhD candidates

Author and co-author of 84 peer-reviewed publications and six chapters in various
books

97 and 60 abstracts in International and Greek conferences, respectively

Head Researcher of 11 clinical and laboratory protocols

Editorial member and reviewer for several greek urology journals

2008- today Director and Chairman of the 1st Dept. of Urology, Athens Medical
School, Laiko Hospital

2009 Professor of Urology, 1st Dept. of Urology, Athens Medical School, Laiko
Hospital

2010 - 2012: Chairman of the Surgical Division of the Laiko Hospital

2012 – today : Chairman of the Scientific Committee, Laiko Hospital
3. Clinical work

Director of the 1st Department of Urology at LAIKO Hospital since September 2008

High-volume surgeon with main interests in urologic oncology, urinary diversion and
orthotopic neobladder formation and lithiasis.
Doctoral Thesis
The contribution of the ureteroscopy and ultrasound in the fragmentation of ureteric calculi.
Athens, 1989.
Selected publications:
1. Constantinides C, Recker F, Jaeger P, Hauri D.: Extracorporeal shock wave lithotripsy as
monotherapy of staghorn renal calculi: 3 years of experience. J Urol. 1989; 142(6):1415-8.
2. Nakopoulou L, Constantinides C, Papandropoulos J, Theodoropoulos G, Tzonou A,
Giannopoulos A, Zervas A, Dimopoulos C.: Evaluation of overexpression of p53 tumor
suppressor protein in superficial and invasive transitional cell bladder cancer: comparison
with DNA ploidy. Urology 1995; 46(3):334-40.
3. Dimopoulos MA, Moulopoulos LA, Costantinides C, Deliveliotis C, Pantazopoulos D,
Dimopoulos C.: Primary renal lymphoma: a clinical and radiological study. J Urol
1996;155(6):1865-7.
4. Dimopoulos MA, Panopoulos C, Bamia C, Deliveliotis C, Alivizatos G, Pantazopoulos D,
Constantinidis C, Kostakopoulos A, Kastriotis I, Zervas A, Aravantinos G, Dimopoulos
C.:Oral estramustine and oral etoposide for hormone-refractory prostate cancer. Urology
1997; 50(5):754-8.
5. Giannopoulos A, Manousakas T, Mitropoulos D, Botsoli-Stergiou E, Constantinides C,
Giannopoulou M, Choremi-Papadopoulou H.: Comparative evaluation of the BTAstat test,
NMP22, and voided urine cytology in the detection of primary and recurrent bladder
tumors. Urology 2000; 55(6):871-5.
6. Stravodimos K, Constantinides C, Manousakas T, Pavlaki C, Pantazopoulos D,
Giannopoulos A, Dimopoulos C.: Immunohistochemical expression of transforming
growth factor beta 1 and nm-23 H1 antioncogene in prostate cancer: divergent correlation
with clinicopathological parameters. Anticancer Res 2000; 20(5C):3823-8.
7. Giannopoulos A, Manousakas T, Gounari A, Constantinides C, Choremi-Papadopoulou
H, Dimopoulos C.: Comparative evaluation of the diagnostic performance of the BTA stat
test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors.
J Urol 2001;166(2):470-5.
8. Bamias A, Deliveliotis Ch, Fountzilas G, Gika D, Anagnostopoulos A, Zorzou MP,
Kastritis E, Constantinides C, Kosmidis P, Dimopoulos MA.: Adjuvant chemotherapy
with paclitaxel and carboplatin in patients with advanced carcinoma of the upper urinary
tract: a study by the Hellenic Cooperative Oncology Group. J Clin Oncol
2004;22(11):2150-4.
9. Liatsikos EN, Karnabatidis D, Kagadis GC, Rokkas K, Constantinides C, Christeas N,
Flaris N, Voudoukis T, Scopa CD, Perimenis P, Filos KS, Nikiforidis GC, Stolzenburg JU,
Siablis D.: Application of Paclitaxel-Eluting Metal Mesh Stents within the Pig Ureter: An
Experimental Study. Eur Urol 2007; 51 (1): 217-23.
10. Jens-Uwe Stolzenburg, Thilo Schwalenberg, Lars-Christian Horn, Jochen Neuhaus,
Costantinos Constantinides, Evangelos N. Liatsikos: Anatomical landmarks of radical
prostatectomy. Eur Urol 2007; 51(3):629-39.
11. Garbis S, Tyritzis S, Roumeliotis T, Zerefos P, Giannopoulou E, Vlahou A, Kossida S, Diaz
J, Vourekas S, Tamvakopoulos C, Pavlakis K, Sanoudou D, Constantinides C: Search for
Potential
Prognosis
Isobaric
Markers
and
Treatment
Tagging
(iTRAQ)
for
in
Prostate
Clinical
with
Tissue
Cancer
Specimens
Two-Dimensional
Liquid
Tandem Mass Spectrometry. J Proteome Res 2008;7(8):3146-58.
Using
Diagnosis,
Amine-Specific
Chromatography
and